Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Atlassian
TEAM
|
$437M |
| 2 |
AbbVie
ABBV
|
$380M |
| 3 |
Workday
WDAY
|
$366M |
| 4 |
Synopsys
SNPS
|
$323M |
| 5 |
Advanced Micro Devices
AMD
|
$286M |
Top Sells
| 1 |
Adobe
ADBE
|
$1.71B |
| 2 |
Apple
AAPL
|
$984M |
| 3 |
Boston Scientific
BSX
|
$642M |
| 4 |
Microsoft
MSFT
|
$599M |
| 5 |
Texas Instruments
TXN
|
$491M |
Sector Composition
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LSI
276
DELISTED
Life Storage, Inc.
LSI
| $127M | 0.06% |
902,740
+136,156
| +18% | +$19.1M |
|
277
Dolby
DLB
$6.96B
| $127M | 0.06% |
1,619,550
-346,768
| -18% | -$27.1M |
|
278
Willis Towers Watson
WTW
$32.1B
| $127M | 0.06% |
535,759
-200,316
| -27% | -$47.3M |
|
279
Clarivate
CLVT
$2.96B
| $125M | 0.06% |
7,472,387
+935,214
| +14% | +$15.7M |
|
280
Invitation Homes
INVH
$18.5B
| $124M | 0.06% |
3,082,608
+568,040
| +23% | +$22.8M |
|
281
CubeSmart
CUBE
$9.52B
| $124M | 0.06% |
2,375,408
+1,833,536
| +338% | +$95.4M |
|
282
Insulet
PODD
$24.5B
| $123M | 0.06% |
462,116
-194,407
| -30% | -$51.8M |
|
283
EnerSys
ENS
$3.89B
| $123M | 0.06% |
1,644,392
-59,788
| -4% | -$4.46M |
|
284
Hartford Financial Services
HIG
$37B
| $121M | 0.06% |
1,685,456
-798,858
| -32% | -$57.4M |
|
285
WNS Holdings
WNS
$3.24B
| $119M | 0.06% |
1,395,349
-93,813
| -6% | -$8.02M |
|
286
Gates Industrial
GTES
$6.68B
| $119M | 0.06% |
7,878,282
-40,508
| -0.5% | -$610K |
|
287
Bio-Techne
TECH
$8.46B
| $119M | 0.06% |
1,095,220
-289,712
| -21% | -$31.4M |
|
|
AGTI
288
DELISTED
Agiliti, Inc.
AGTI
| $118M | 0.06% |
5,608,422
-218,845
| -4% | -$4.62M |
|
289
Interpublic Group of Companies
IPG
$9.94B
| $118M | 0.06% |
3,332,431
-748,042
| -18% | -$26.5M |
|
290
WIX.com
WIX
$8.52B
| $118M | 0.06% |
1,128,976
-15,126
| -1% | -$1.58M |
|
291
Regeneron Pharmaceuticals
REGN
$60.8B
| $118M | 0.06% |
168,702
-10,276
| -6% | -$7.18M |
|
292
Moderna
MRNA
$9.78B
| $117M | 0.06% |
679,114
-159,081
| -19% | -$27.4M |
|
293
Cardinal Health
CAH
$35.7B
| $114M | 0.06% |
2,007,424
+314,529
| +19% | +$17.8M |
|
294
Air Products & Chemicals
APD
$64.5B
| $112M | 0.05% |
447,271
-476,504
| -52% | -$119M |
|
295
United Therapeutics
UTHR
$18.1B
| $110M | 0.05% |
612,962
+544,649
| +797% | +$97.7M |
|
296
VF Corp
VFC
$5.86B
| $110M | 0.05% |
1,933,548
+79,888
| +4% | +$4.54M |
|
297
Sea Limited
SE
$113B
| $110M | 0.05% |
916,874
-221,626
| -19% | -$26.5M |
|
298
Royalty Pharma
RPRX
$15.6B
| $108M | 0.05% |
2,782,826
+212,647
| +8% | +$8.28M |
|
299
Nordson
NDSN
$12.6B
| $108M | 0.05% |
476,164
-63,209
| -12% | -$14.4M |
|
300
Glaukos
GKOS
$5.39B
| $108M | 0.05% |
1,870,069
+290,043
| +18% | +$16.8M |
|